Cancer is one of Malaysia’s leading causes of death. But early detection can change everything—enabling less invasive treatment, higher survival rates, and better long-term outcomes.
At SuperDNA, we’re proud to be the first company in Malaysia to offer Whole Genome Sequencing (WGS) for advanced genetic testing. With our cutting-edge liquid biopsy technology, we offer a non-invasive, highly accurate method to detect multiple types of cancer at its earliest—and most treatable—stages.
🔍 What Is a Liquid Biopsy?
A liquid biopsy is a simple blood test that detects signs of cancer by analyzing materials released into your bloodstream by tumors. These include:
-
Circulating Tumor DNA (ctDNA) – small fragments of DNA shed by cancer cells
-
Circulating Tumor Cells (CTCs) – whole cancer cells that break off and enter the bloodstream
Liquid biopsy enables early cancer detection, treatment monitoring, and recurrence tracking—all without invasive procedures.
⚖️ ctDNA vs. CTCs: What’s the Difference?
While both biomarkers are used in cancer detection, ctDNA has emerged as the more reliable and practical choice for routine screening.
🔬 Comparison Table: ctDNA vs. CTCs
| Feature | CTCs (Circulating Tumor Cells) | ctDNA (Circulating Tumor DNA) |
|---|---|---|
| What it is | Whole cancer cells in the blood | DNA fragments from tumor cells |
| Detection in early cancer | Limited – often undetectable | High – detectable even in early stages |
| Stability | Fragile and short-lived | More stable and easier to analyze |
| Lab complexity | Requires specialized processing | Scalable with modern sequencing |
| Cost | Higher due to complexity | More affordable and widely used |
| Best used for | Advanced cancer profiling | Early detection, mutation analysis, recurrence tracking |
Because ctDNA offers higher sensitivity and stability, SuperDNA’s Multi-Cancer Early Detection Test focuses on ctDNA analysis—making it ideal for real-world application in Malaysia’s healthcare landscape. Find out more about Cancer Detect here.
💡 Real-World Applications of Liquid Biopsy
✅ 1. Multi-Cancer Early Detection (MCED)
One test can detect multiple types of cancer, including but not limited to:
-
Breast
-
Lung
-
Colorectal
-
Prostate
-
Liver
-
Ovarian
-
Pancreatic
This makes liquid biopsy ideal for annual cancer screening, especially for individuals with family history or elevated risk.
✅ 2. Pre-Symptomatic Detection
Studies show that ctDNA can reveal cancer-related mutations before symptoms appear, as early as stage 1, enabling life-saving early intervention.
✅ 3. Monitoring Treatment & Recurrence
Liquid biopsy can track cancer treatment progress and detect relapse earlier than traditional scans, enabling faster, more targeted responses.
🧬 Why Choose SuperDNA for Cancer Detection?
As the pioneer of Whole Genome Sequencing in Malaysia, SuperDNA combines clinical-grade technology with in-house lab expertise to deliver:
-
High-sensitivity liquid biopsy testing
-
Accurate analysis of circulating tumor DNA
-
Non-invasive sample collection (blood or saliva)
-
Comprehensive reporting + expert consultation
Whether you’re looking to screen proactively, confirm family risk, or monitor past conditions, SuperDNA offers trusted, science-backed solutions tailored to you.
🧭 Who Should Consider a Liquid Biopsy?
-
Individuals with a family history of cancer
-
Those seeking non-invasive annual screening
-
Cancer survivors monitoring for recurrence
-
Anyone focused on preventive health and early intervention
🧪 How It Works
-
Order online at mysuperdna.com/shop
-
Receive a blood sample collection kit
-
Return your sample via courier or clinic visit
-
Get your results and report within 14–21 working days
-
Review with our expert consultants
🌱 Take Control of Your Health Today
Early detection saves lives. With SuperDNA’s liquid biopsy and WGS-powered testing, you no longer need to wait for symptoms to act.
Explore our best-in-class genetic cancer screening options today:
